Fresenius SE & Co. (FSNUY)
(Delayed Data from OTC)
$9.28 USD
-0.04 (-0.43%)
Updated Sep 25, 2024 03:50 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FSNUY 9.28 -0.04(-0.43%)
Will FSNUY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FSNUY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FSNUY
Is Fresenius SE & Co. (FSNUY) a Great Value Stock Right Now?
FSNUY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for FSNUY
Positive Report for Fresenius SE & Co. KGaA (0OO9) from J.P. Morgan
GLOBAL BROKER RATINGS: Jefferies raises BASF, JPMorgan cuts Moderna
IN THE KNOW: "Medicine starting to work" at Fresenius - JPMorgan
Fresenius SE just upgraded at JPMorgan, here's why
Fresenius: Showing Signs Of Recovery, We Have Dawn